Financhill
Sell
28

RGBP Quote, Financials, Valuation and Earnings

Last price:
$0.0100
Seasonality move :
32.11%
Day range:
$0.0084 - $0.0109
52-week range:
$0.0038 - $0.1169
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.62x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
817.8K
1-year change:
-91.6%
Market cap:
$464K
Revenue:
$236.6K
EPS (TTM):
-$0.15

Earnings Data

Next earnings date for RGBP
--
Most recent earnings per share
-$0.01
Missed by $0.01
(Aug 11/2025)
Consensus Estimate
--
(Aug 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RGBP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/11/2025 Q2 -- $59.1K -$0.01 -- --
05/28/2025 Q1 -- $59.1K -$0.00 -- --
01/31/2025 Q4 -- $59.1K -$0.13 -- --
09/30/2024 Q3 -- $59.4K -$0.06 -- --
08/13/2024 Q2 -- $59.1K -$0.02 -- --
04/24/2024 Q1 -- $59.1K -$0.01 -- --
01/19/2024 Q4 -- $59.1K -$0.02 -- --
09/30/2023 Q3 -- $59.4K -$0.04 -- --
07/25/2023 Q2 -- $59.1K -$0.01 -- --
03/31/2023 Q1 -- $59.1K -$0.02 -- --
12/31/2022 Q4 -- $59.1K $0.22 -- --
09/30/2022 Q3 -- $59.4K -$0.01 -- --
06/30/2022 Q2 -- $58.7K $9.56 -- --
03/31/2022 Q1 -- $58.4K -$11.03 -- --
12/31/2021 Q4 -- $59.1K $0.40 -- --
09/30/2021 Q3 -- $59.7K -$0.24 -- --
06/30/2021 Q2 -- $56.6K -$1.58 -- --
03/31/2021 Q1 -- $27.4K $0.12 -- --
12/31/2020 Q4 -- $27.4K $0.59 -- --
09/30/2020 Q3 -- $27.7K $0.45 -- --
06/30/2020 Q2 -- $27.4K $1.20 -- --
03/31/2020 Q1 -- $27.4K -$1.94 -- --
12/31/2019 Q4 -- $27.4K $2.17 -- --
09/30/2019 Q3 -- $27.7K $2.34 -- --
06/30/2019 Q2 -- $27.4K -$38.51 -- --
03/31/2019 Q1 -- $27.4K -$0.85 -- --
12/31/2018 Q4 -- $27.4K $0.51 -- --
09/30/2018 Q3 -- -- -$4.34 -- --
06/30/2018 Q2 -- $100K -$0.53 -- --
03/31/2018 Q1 -- -- -$5.84 -- --
12/31/2017 Q4 -- -- -$14.63 -- --
09/30/2017 Q3 -- -- -$6.75 -- --
06/30/2017 Q2 -- $110K -$14.25 -- --
03/31/2017 Q1 -- -- -$6.98 -- --
12/31/2016 Q4 -- -- -$2.93 -- --
09/30/2016 Q3 -- $100K -$5.40 -- --
06/30/2016 Q2 -- -- -$5.85 -- --
03/31/2016 Q1 -- -- -$4.35 -- --
12/31/2015 Q4 -- -- -$4.43 -- --

Regen Biopharma, Inc. Earnings Questions

  • How Much did Regen Biopharma, Inc. Generate in Revenue Last Quarter?

    Regen Biopharma, Inc. reported $59.1K worth of top line sales in its most recent quarter.

  • Did Regen Biopharma, Inc. Beat Earnings Last Quarter?

    Regen Biopharma, Inc. announced earnings per share of -$0.01 which represents a miss of analyst forecast a -- per share.

  • Is Regen Biopharma, Inc. Profitable?

    Regen Biopharma, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Regen Biopharma, Inc. EPS Next Year?

    Regen Biopharma, Inc.'s earnings are forecast to grow from -$0.08 per share to -- per share next year representing an increase of --.

  • When is Regen Biopharma, Inc.'s Earnings Date?

    Currently, Regen Biopharma, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 18, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Tesla Stock Go Up In 2026?
Will Tesla Stock Go Up In 2026?

EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…

What Are the Best AI Power Stocks?
What Are the Best AI Power Stocks?

As the construction of AI infrastructure accelerates, the gap between…

Is IONQ The Best Quantum Stock to Buy?
Is IONQ The Best Quantum Stock to Buy?

Riding a wave of investor enthusiasm for the technology, quantum…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
40
HUT alert for Dec 17

Hut 8 Corp. [HUT] is up 12.08% over the past day.

Sell
39
SMX alert for Dec 17

SMX (Security Matters) Plc [SMX] is up 22.55% over the past day.

Sell
45
ZBIO alert for Dec 17

Zenas BioPharma, Inc. [ZBIO] is down 2.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock